CUSIP: G9845F117
What is CUSIP G9845F117?
CUSIP G9845F117 identifies LSBPW - LakeShore Biopharma Co., Ltd. - *W EXP 03/15/202 in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Open recent reporting periods for CUSIP G9845F117:
As of 31 Dec 2025, 2 institutional investors reported holding 10,050 shares of LakeShore Biopharma Co., Ltd. - *W EXP 03/15/202 (LSBPW).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 10,050 | $50 | $0.01 | 2 | |
| 2025 Q3 | 10,050 | $32 | -$196,360 | $0.00 | 2 |
| 2025 Q2 | 5,005,114 | $198,665 | +$41,753 | $0.04 | 17 |
| 2025 Q1 | 4,087,645 | $194,790 | -$10,463 | $0.04 | 17 |
| 2024 Q4 | 4,143,393 | $380,818 | +$53,146 | $0.08 | 18 |
| 2024 Q3 | 4,038,483 | $258,410 | -$96,364 | $0.07 | 21 |
| 2024 Q2 | 4,920,424 | $402,582 | -$9,791 | $0.09 | 21 |
| 2024 Q1 | 4,104,683 | $294,845 | -$18,438 | $0.07 | 21 |
| 2023 Q4 | 4,195,638 | $157,349 | -$17,865 | $0.04 | 22 |
| 2023 Q3 | 6,318,659 | $251,647 | -$2,976 | $0.04 | 28 |
| 2023 Q2 | 6,385,283 | $301,751 | -$327,360 | $0.05 | 29 |
| 2023 Q1 | 5,470,332 | $1,140,308 | +$1,062,508 | $0.16 | 28 |